Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Authors:
- Elizabeth K. AllisonEAElizabeth K. Allison
- Joseph El KhouryJKJoseph El Khoury
Top Cited Papers
Open Access
- 13 August 2008
- journal article
- research article
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 28 (33) , 8354-8360
Abstract
Early microglial accumulation in Alzheimer's disease (AD) delays disease progression by promoting clearance of β-amyloid (Aβ) before formation of senile plaques. However, persistent Aβ accumulation despite increasing microglial numbers suggests that the ability of microglia to clear Aβ may decrease with age and progression of AD pathology. To determine the effects of aging and Aβ deposition on microglial ability to clear Aβ, we used quantitative PCR to analyze gene expression in freshly isolated adult microglia from 1.5-, 3-, 8-, and 14-month-old transgenic PS1-APP mice, an established mouse model of AD, and from their nontransgenic littermates. We found that microglia from old PS1-APP mice, but not from younger mice, have a twofold to fivefold decrease in expression of the Aβ-binding scavenger receptors scavenger receptor A (SRA), CD36, and RAGE (receptor for advanced-glycosylation endproducts), and the Aβ-degrading enzymes insulysin, neprilysin, and MMP9, compared with their littermate controls. In contrast, PS1-APP microglia had a 2.5-fold increase in the proinflammatory cytokines IL-1β (interleukin-1β) and tumor necrosis factor α (TNFα), suggesting that there is an inverse correlation between cytokine production and Aβ clearance. In support of this possibility, we found that incubation of cultured N9 mouse microglia with TNFα decreased the expression of SRA and CD36 and reduced Aβ uptake. Our data indicate that, although early microglial recruitment promotes Aβ clearance and is neuroprotective in AD, as disease progresses, proinflammatory cytokines produced in response to Aβ deposition downregulate genes involved in Aβ clearance and promote Aβ accumulation, therefore contributing to neurodegeneration. Antiinflammatory therapy for AD should take this dichotomous microglial role into consideration.Keywords
This publication has 28 references indexed in Scilit:
- Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic MiceThe American Journal of Pathology, 2007
- Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in SituJournal of Biological Chemistry, 2006
- Neuropathology of Alzheimer's DiseaseNeuroimaging Clinics Of North America, 2005
- Expression of Scavenger Receptors in Glial CellsJournal of Biological Chemistry, 2005
- Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature DeathNeuron, 2003
- Co-expression of multiple transgenes in mouse CNS: a comparison of strategiesBiomolecular Engineering, 2001
- The Origins of Alzheimer DiseaseJAMA, 2000
- Microglia in Alzheimer's Disease and Transgenic ModelsThe American Journal of Pathology, 1999
- Activation of microglial cells by β-amyloid protein and interferon-γNature, 1995
- Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.1988